Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Intellia Therapeutics Inc Logo

ARKG Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Maxinomics.com icon
YouTube Logo
Date
Direction
Shares
Fund Weight
Fund
September 19, 2022
BUY17.959k0.0427%ARKG
September 16, 2022
BUY83.502k0.1856%ARKG
April 14, 2022
BUY13.763k0.0248%ARKG
April 13, 2022
BUY1.109k0.002%ARKG
April 12, 2022
BUY5.691k0.0104%ARKG

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$46.12
⚖️Weighting🧢Market Cap
3.64%$3.93b
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
1176.48
🏋️‍♀️Weight Rank Across All Funds🌏Country
10🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$54.512.27%
Description
Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products.
Website
www.intelliatx.com